Literature DB >> 28096917

Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound.

Michele Billia1, Khurram M Siddiqui1, Susanne Chan2, Fan Li1, Ali Al-Zahrani3, Jose A Gomez2, Joseph L Chin1.   

Abstract

INTRODUCTION: Local recurrence of prostate cancer (PCa) following radiotherapy may be treated with curative intent using salvage high-intensity focused ultrasound (s-HIFU). The interpretation of needle core biopsy specimens following s-HIFU is a daunting task, even for experienced pathologists. We describe various histopathological features encountered in biopsy specimens following whole-gland s-HIFU in one of the largest descriptive studies to date.
METHODS: Fifty-five patients with biopsy-proven localized radio-recurrent PCa underwent s-HIFU and transrectal ultrasound (TRUS)-guided prostatic needle biopsies at 180 days post-treatment. All biopsies were reviewed by two genitourinary pathologists.
RESULTS: PCa was detected in 11 (24%) biopsies. Radiation therapy-associated changes were identified in all cases. Additional findings included extensive coagulative stromal necrosis (100%), smudgy chromatin of cancer nuclei (82%), and markedly enlarged bizarre nuclei in the residual cancer (55%). Gleason grade assignment was possible in 10 (91%) of these biopsies and concordance of Gleason grading between pre- and post-therapy specimens was observed in six (60%) cases.
CONCLUSIONS: The histological interpretation of needle biopsies following salvage HIFU is challenging and requires an understanding of the histopathological changes associated with this procedure in both tumoural and non-tumoural prostatic tissue. Accurate interpretation of the morphological changes following s-HIFU is instrumental for optimization of clinical decision-making and treatment planning in recurrent PCa.

Entities:  

Year:  2016        PMID: 28096917      PMCID: PMC5167599          DOI: 10.5489/cuaj.3918

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  25 in total

Review 1.  High-intensity focused ultrasound: where are we and where to from here?

Authors:  Andrew K Williams; C H Martínez; V Chalasani; J Chin
Journal:  Expert Rev Anticancer Ther       Date:  2010-01       Impact factor: 4.512

2.  Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

Authors:  W U Shipley; H D Thames; H M Sandler; G E Hanks; A L Zietman; C A Perez; D A Kuban; S L Hancock; C D Smith
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

3.  Histologic changes of irradiated prostatic carcinoma diagnosed by transrectal ultrasound.

Authors:  D B Siders; F Lee
Journal:  Hum Pathol       Date:  1992-04       Impact factor: 3.466

4.  Salvage high-intensity focused ultrasound for patients with recurrent prostate cancer after brachytherapy.

Authors:  Vladimir Yutkin; Hashim U Ahmed; Ian Donaldson; Neil McCartan; Khurram Siddiqui; Mark Emberton; Joseph L Chin
Journal:  Urology       Date:  2014-10-24       Impact factor: 2.649

5.  Prostatic needle biopsies following primary high intensity focused ultrasound (HIFU) therapy for prostatic adenocarcinoma: histopathological features in tumour and non-tumour tissue.

Authors:  Paul Ryan; Antonio Finelli; Nathan Lawrentschuk; Neil Fleshner; Joan Sweet; Carol Cheung; Theodorus van der Kwast; Andrew Evans
Journal:  J Clin Pathol       Date:  2012-06-01       Impact factor: 3.411

Review 6.  Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma.

Authors:  C D Petraki; C P Sfikas
Journal:  Histol Histopathol       Date:  2007-01       Impact factor: 2.303

7.  The feasibility and safety of high-intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy.

Authors:  Evangelos Zacharakis; Hashim U Ahmed; Ayesha Ishaq; Rebecca Scott; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  BJU Int       Date:  2008-06-28       Impact factor: 5.588

8.  Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients.

Authors:  F Civantos; M A Marcial; E R Banks; C K Ho; V O Speights; P A Drew; W M Murphy; M S Soloway
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

9.  Radiation injury of the normal and neoplastic prostate.

Authors:  D G Bostwick; B M Egbert; L F Fajardo
Journal:  Am J Surg Pathol       Date:  1982-09       Impact factor: 6.394

Review 10.  Diagnosis of prostatic carcinoma after therapy.

Authors:  David G Bostwick; Isabelle Meiers
Journal:  Arch Pathol Lab Med       Date:  2007-03       Impact factor: 5.534

View more
  1 in total

1.  Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?

Authors:  Raïssa Lotte; Alexandre Lafourcade; Pierre Mozer; Pierre Conort; Eric Barret; Eva Comperat; Malek Ezziane; Paul-Hugo Jouve de Guibert; Sebastian Tavolaro; Lisa Belin; Franck Boudghene; Olivier Lucidarme; Raphaële Renard-Penna
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.